Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 21, 2007; 13(7): 1003-1009
Published online Feb 21, 2007. doi: 10.3748/wjg.v13.i7.1003
Published online Feb 21, 2007. doi: 10.3748/wjg.v13.i7.1003
Table 3 Multivariate analysis for factors associated with survival
| Variables | Risk ratio (95% CI) | P |
| Tumor size (cm) | ||
| > 3 | 1.0 | |
| ≤ 3 | 0.459 (0.179-1.174) | 0.104 |
| Serum PIVKA-II level (ng/mL) | ||
| ≥ 300 | 1.0 | |
| < 300 | 0.542 (0.191-1.535) | 0.249 |
| Serum albumin level (g/dL) | ||
| > 3.5 | 1.0 | |
| ≤ 3.5 | 3.216 (1.407-7.353) | 0.006 |
| Initial treatment response | ||
| Successful | 1.0 | |
| Unsuccessful | 2.474 (1.076-5.692) | 0.033 |
- Citation: Morimoto M, Numata K, Sugimori K, Shirato K, Kokawa A, Oka H, Hirasawa K, Koh R, Nihommatsu H, Tanaka K. Successful initial ablation therapy contributes to survival in patients with hepatocellular carcinoma. World J Gastroenterol 2007; 13(7): 1003-1009
- URL: https://www.wjgnet.com/1007-9327/full/v13/i7/1003.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i7.1003